Augusta University
Children with recurrent brain tumors or newly diagnosed, particularly aggressive tumors called diffuse intrinsic pontine gliomas are being enrolled in the first study to examine the efficacy of a drug that inhibits an enzyme these tumors use to...
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say. High levels of this enzyme, indoleamine 2,3 dioxygenase, or IDO, at...
A clinical trial at the Georgia Cancer Center at Augusta University featuring a homegrown discovery is drawing kids from other prestigious cancer centers across the country. These children are being treated with Indoximod, an inhibitor of the enzyme...
